Hostname: page-component-7c8c6479df-r7xzm Total loading time: 0 Render date: 2024-03-29T10:56:29.168Z Has data issue: false hasContentIssue false

Optimal length of continuation therapy: A prospective assessment during fluoxetine long-term treatment of major depressive disorder

Published online by Cambridge University Press:  16 April 2020

D. Michelson
Affiliation:
Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA
M. Wilson
Affiliation:
Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA
K. Sundell
Affiliation:
Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA
C. Beasley
Affiliation:
Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Symposia
Copyright
Copyright © European Psychiatric Association 1998
Submit a response

Comments

No Comments have been published for this article.